Table 1 Characteristics of 64 non-metastatic posttreatment nasopharyngeal carcinoma patients diagnosed with COVID-19
Characteristics | Relapse | p | |
|---|---|---|---|
Yes n (%) | No n (%) | ||
Total | 12 (18.75) | 52 (81.25%) | |
Age(y) | 0.200 | ||
≤ 50 | 4 (33.3) | 28 (53.8) | |
> 50 | 8 (66.7) | 24 (46.2) | |
Sex | 0.739 | ||
Male | 9 (75.0) | 35 (67.3) | |
Female | 3 (25.0) | 17 (32.7) | |
T stage | 0.510 | ||
T1–2 | 3 (25.0) | 21 (26.0) | |
T3–4 | 9 (75.0) | 31 (74.0) | |
N stage | 0.907 | ||
N0–1 | 5 (41.7) | 25 (48.1) | |
N2–3 | 7 (58.3) | 27 (51.9) | |
TNM stage | 0.274 | ||
1–2 | 1 (8.3) | 13 (25.0) | |
3–4 | 11 (91.7) | 39 (75.0) | |
Symptoms of COVID-19 | 0.186 | ||
No | 0 (0.0) | 10 (19.2) | |
Yes | 12 (100.0) | 42 (80.8) | |
Fever | 0.181 | ||
No | 3 (25.0) | 24 (46.2) | |
Yes | 9 (75.0) | 28 (53.8) | |